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Summary
Background: We are performing a nationwide survey in a ran-
dom sample of German general practitioners (GPs), orthoped-
ists, and internists on the use of placebos and nonspecific as 
well as complementary treatments and their association with 
basic professional attitudes. In this article we explain the theo-
retical considerations behind the study approach and the de-
velopment of the questionnaire. Methods: Based on a system-
atic review of published surveys, own surveys on the topic, 
and on theoretical considerations we developed a preliminary 
version of a 4-page questionnaire that was tested for feasibility 
in a convenience sample of 80 participants of a general medi-
cal education event. We also performed cognitive interviews 
with 8 physicians to investigate whether the questions were 
understood adequately. Results: The questions on typical pla-
cebos and complementary treatments were well understood 
and easy to answer for participants. Discussions about the 
phrasing of questions on nonspecific treatments during inter-
view reflected the vagueness of this concept; but this did not 
seem to create major problems when answering the related 
questions. The original questions regarding basic professional 
attitudes partly were not understood in the manner intended. 
The relevant questions were modified but the interviews sug-
gest that these issues are difficult to grasp in a quantitative 
survey. Conclusion: Our testing procedures suggest that our 
questionnaire is well-suited to investigate our questions with 
some limitations regarding the issue of basic professional at-
titudes.
Schlüsselwörter
Placebos ⋅ Placeboeffekt ⋅ Komplementäre Therapien ⋅ 
Querschnittstudie ⋅ Deutschland
Zusammenfassung
Hintergrund: Die Autoren führen derzeit eine Befragung einer 
Zufallsstichprobe niedergelassener Allgemeinmediziner, Ortho-
päden und Internisten in Deutschland durch. Erhoben wird die 
Verwendung von Placebos sowie unspezifischen und komple-
mentären Therapien und damit verbundenen berufsethischen 
Grundhaltungen. Im vorliegenden Artikel werden die theore-
tischen Hintergründe und die Entwicklung des  verwendeten 
Fragebogens dargestellt. Methoden: Basierend auf einem sys-
tematischen Review veröffentlichter Umfragen, eigenen Erhe-
bungen zu diesem Thema und theoretischen  Überlegungen 
wurde eine vorläufige Version eines 4-seitigen Fragebogens 
entwickelt und 80 Teilnehmern einer allgemeinmedizinischen 
Fortbildungsveranstaltung vorgelegt. Zusätzlich wurden kogni-
tive Interviews mit 8 Ärzten durchgeführt, um das Verständnis 
der Fragen qualitativ zu überprüfen.  Ergebnisse: Die Fragen zu 
typischen Placebos und komplementären Verfahren wurden 
problemlos verstanden und beantwortet. Die Formulierung der 
Fragen zu unspezifischen Therapien führte regelhaft zu Diskus-
sionen, die die Unklarheit dieses Konzepts reflektierten; dies 
schien jedoch nicht zu größeren Verständnisproblemen bezüg-
lich der Beantwortung daran anlehnender Fragen zu führen. Ein 
Teil der Fragen zu berufsethischen Grundhaltungen wurde da-
gegen teilweise nicht in der von uns intendierten Weise verstan-
den. Die relevanten Fragen wurden zwar modifiziert, aber die 
Interviews legen nahe, dass die entsprechenden Informationen 
mit standardisierten Fragebögen nur eingeschränkt erfassbar 
sind. Schlussfolgerung: Die Prüfverfahren sprechen dafür, dass 
unser Fragebogen für die Erreichung der Studienziele insge-
samt gut geeignet ist, obgleich sich die berufsethische Grund-
haltung nur schwer quantitativ erfassen lässt.
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difficult situations in routine practice. They argue that such 
prescribing behavior, while being considered irrational from a 
medico-scientific perspective, is rational in the broadest sense 
of problem-solving acknowledging the humanity of the thera-
peutic relationship. This challenges the usual definition of ra-
tional prescribing. Further, qualitative studies on the inade-
quate prescription of antibiotics in case of sore throats or colds 
[10, 11] found even more evidence suggesting that GPs do not 
apply nonspecific interventions mainly to trigger placebo ef-
fects. In these studies the word placebo or the idea of trigger-
ing placebo effects did not come up at all while surveys on the 
use of placebo often consider this as a typical example of a 
placebo prescription [1].
Compared to other specialties, the use of nonspecific inter-
ventions or impure placebos seems to be particularly wide-
spread among GPs [1, 6, 12–14]. This is plausible when consid-
ering that GPs see many patients with complaints not easy to 
diagnose precisely [15] and who have minor ailments [16]. We 
would expect that for specialists of internal medicine who 
mainly see preselected cases with more advanced disease and 
clear diagnoses receiving multiple treatments, the use of im-
pure placebo is less often an option. We speculate that ortho-
pedic specialists in private practice are a particularly interest-
ing group with respect to our subject but we are not aware of 
any studies investigating placebo use among this group. Ortho-
pedists are trained in hospitals with strong emphasis on surgi-
cal techniques while in private practice they see a lot of pa-
tients with relatively nonspecific complaints [17]. One could 
therefore assume that orthopedists often feel strong uncer-
tainty towards their patients and do not have straightforward 
evidence-based treatment options. Thus, we would expect that 
they use nonspecific treatments less often than GPs but more 
often than specialists in internal medicine. 
We hypothesize that there should also be a relation be-
tween the use of complementary and alternative treatments 
(such as herbal medicine, acupuncture, homeopathy, chiro-
practic or osteopathy) and nonspecific treatments. Comple-
mentary medicine offers, or seems to offer, ‘specific’ diagnostic 
and therapeutic solutions for many patients for whom conven-
tional medicine does not provide satisfactory answers. Believ-
ing in the efficacy and using complementary treatments could 
therefore be a way of reducing uncertainty and keeping pro-
fessional ideals (while maybe implying some conflict with pro-
fessional orthodoxy). If this proved true, one should expect 
that providers of complementary treatments have less need 
for using treatments they personally consider to be nonspecif-
ic. At the same time we think that convinced providers of com-
plementary treatments also believe in a strong mind-body con-
nection and strong placebo effects. One could therefore as-
sume that they are more open towards the use of placebo 
interventions. Finally, a consistent finding in surveys from 
 Germany and Switzerland is that many physicians use comple-
mentary treatment as impure placebos / nonspecific interven-
tion [6, 13, 18]. It would be interesting to know whether these 
Theoretical Considerations for Questionnaire Development
While most published placebo surveys include questions on 
reasons and motives for the use of placebos and nonspecific 
treatments authors rarely discuss on a conceptual level why 
physicians use such interventions. It seems that many survey 
authors implicitly think that eliciting placebo effects is a major 
motive and that the use of placebo interventions would be le-
gitimate if the patient would not be deceived. Instead, our cen-
tral assumption is that impure placebos / nonspecific treat-
ments are applied to deal with uncertain and difficult situations 
in clinical practice. This assumption is based on a number of 
qualitative investigations exploring reasons why physicians 
sometimes use interventions they do not consider active or ad-
equate. In a study by Comaroff [7] published in 1976 the atti-
tudes of 51 GPs in Wales toward placebos and nonspecific 
treatments were surveyed indirectly, in the context of a more 
general discussion about prescribing behavior. Practitioners 
were first asked to estimate the proportion of their consulta-
tions culminating in a treatment prescription. All participants 
set the proportion at 70% or higher. In their elaborate answers, 
most practitioners spontaneously stated that they did not con-
sider all prescriptions as truly necessary and felt necessitated to 
provide justifications. Implicitly the answers clearly indicated 
that the physicians had internalized a professional ideal requir-
ing that any treatment should be specific in effect and adminis-
tered or prescribed only when necessary. However, this ideal 
conflicted with the realities of GPs in routine practice. Seeing 
only unselected patients, GPs faced considerable uncertainty 
but still needed to make decisions. On the one hand, making a 
firm diagnosis in general practice was often impossible or un-
necessary, implying that the basis for choosing a specific treat-
ment was weak. On the other hand, physicians usually believed 
that patients expected a clear diagnosis and a treatment. There-
fore, the GPs often used nonspecific treatments.
Research on difficult prescribing situations also suggests 
that ideals and self-perception of physicians might be more 
important reasons for prescribing placebos or nonspecific 
treatment than the triggering of placebo effects. Henriksen 
and Hansen [8] interviewed 20 GPs to investigate their self-
perception in relation to prescribing medicine. The study fo-
cused on threats to the self-image in a general manner, but 
clearly nonspecific interventions played a major role. Also this 
study found that an orientation towards human or scientific 
ideals was implicitly fundamental to the physicians. However, 
multiple factors made it difficult to live up to the ideals. Due to 
patient demand, lack of time or the need to do any kind of 
treatment physicians gave prescriptions against their convic-
tions in given situations. To be able to face themselves in the 
mirror physicians developed strategies to protect themselves. 
They tried to set the ideals realistically, take a stand, and be-
lieve in themselves. A qualitative study by Weiss and Scott [9] 
suggests that nonspecific interventions (called ‘irrational pre-
scribing’ in the paper) and prescribing in general are seen as a 
problem-solving tool which can be used to manage a variety of 
Introduction
Surveys on the use of placebo interventions have shown 
that between 17 and 80% of physicians have applied ‘pure’ 
placebos (treatments which are devoid of any intrinsic activity, 
e.g., sugar tablets or saline injections) at some point during 
their professional life [1]. The actual frequency of the use of 
pure placebo seems, however, to be rare. Outside hospital 
walls the use of so-called ‘impure’ placebos is much more fre-
quent [1]. The term impure placebos is used in the academic 
discussion to denote treatments thought to be active in princi-
ple, but considered to have no activity over placebo in the ac-
tual patient being treated; e.g., an antibiotic for uncomplicated 
upper respiratory tract infection. Exact estimations how fre-
quently such interventions are used are difficult as definitions 
of when a treatment becomes an impure placebo are variable 
and underlie subjective interpretations [1]. As the concept of 
impure placebo is not intuitively understood by practising 
physicians in Germany and might be misleading [1, 2] we like-
wise use the term nonspecific treatments in this article, al-
though this term is problematic, too. 
While the German Medical Association recently published 
a detailed state of the art report on placebo in research, prac-
tice, and legal issues [3] little is known about the actual use of 
such therapies in Germany. Two studies published in 1981 [4] 
and 2009 [5] investigated the application of pure placebos in 
hospitals. Both studies provide evidence that pure placebos 
have been applied by many physicians, however, in rare in-
stances. Our own group recently sent a questionnaire about 
placebo use to 400 general practitioners (GPs) in Bavaria [6]. 
The response rate was 55% with 45% of responding GPs hav-
ing used pure placebos in the last year (median frequency 5, 
interquartile range 2–10). 76% reported that they had used 
impure placebos at least once during the last year, with a me-
dian frequency of 20 times per year (interquartile range 10–
50). When asked for reasons for the use of placebos physicians 
most often chose the following options from a predefined list: 
a psychological effect (reported by 77% of pure placebo users 
and 79% of impure placebo users), the expectations of pa-
tients to receive a treatment (57 and 52%), the handling of 
difficult treatment situations (47 and 46%), offering an addi-
tional treatment option to suffering patients (19 and 47%), 
and nonspecific complaints (42 and 31%). There is no data 
available on the use of placebo interventions by German phy-
sicians specialized in other fields.
We decided to perform a nationwide survey in a random 
sample of GPs, orthopedists, and internists on the use of place-
bos as well as nonspecific and complementary treatments and 
their association with basic professional attitudes. We are not 
aware of other studies that tried to link these subjects in the 
way we do, so we hope that our survey will be able to provide 
new insights. In this article we explain the theoretical consid-
erations behind our approach and the development of our 
questionnaire.
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physicians have sceptic attitudes towards complemen tary 
medicine.
Based on the considerations summarized above, we would 
like to test the following hypotheses: 
1. We expect that in all 3 groups (GPs, internists, and orthope-
dists) impure placebos / nonspecific interventions are used 
broadly and more frequently than pure placebos.
2.  GPs use impure placebos / nonspecific interventions and 
complementary therapies more often than physicians spe-
cialized in internal medicine.
3.  Orthopedists use impure placebos / nonspecific interven-
tions and complementary therapies more often than in-
ternists (although we are somewhat uncertain whether or-
thopedists are willing to classify their actions in that way).
We will also investigate whether characteristics of physi-
cians (regardless of specialization) using pure placebos only, 
using nonspecific therapies only or using both placebos and 
nonspecific therapies differ from those reporting to neither 
use pure placebos nor nonspecific interventions. We did not 
formulate explicit hypotheses regarding associations between 
basic professional attitudes and the frequency of impure pla-
cebo use, as we are uncertain whether our quantitative survey 
will truly grasp professional attitudes in a sufficiently valid 
manner. We believe that the true reasons for the use of impure 
placebos / nonspecific interventions should mainly be investi-
gated using qualitative methods (therefore, we also aim to per-
form such a study). Nevertheless we will try to investigate the 
association between statements regarding some basic profes-
sional attitudes based on the considerations above and the use 
of such interventions.
Methods of Questionnaire Development
Based on our systematic review of surveys [1], our previous survey [6], 
informal discussions with GPs, and the theoretical considerations sum-
marized above we developed a pilot version of a questionnaire. The pilot 
version was then handed out at a continuing education event for GPs to 
about 120 participants of whom 80 returned the completed questionnaires 
(pretest). Participants were asked to give their comments on the question-
naire on the last page. Based on the results of this pretest we slightly mod-
ified the questionnaire. Then a total of 7 so-called cognitive interviews 
with 8 physicians (4 general practitioners, 3 internists, and 1 orthopedist; 
duration between 34 and 90 min) were performed to check whether phy-
sicians understood the questions in the way intended by the investigators. 
In survey research such interviews are performed to understand the cog-
nitive processes when individuals answer questions [19]. The main tech-
nique used was probing (asking additional questions to check whether 
physicians had understood items in the way intended). Physicians were 
first asked to fill in the questionnaire. They were asked to do it in the 
same speed as if they would do when participating in a postal survey. The 
interviews then were performed according to a semi-structured guideline 
allowing considerable flexibility. Areas of particular interest were how 
physicians understood the terms placebo and nonspecific therapies, and 
whether physicians understood some more difficult questions regarding 
their attitudes. Interviews were recorded with audio tape. The audio 
tapes were analyzed independently by 2 investigators and summarized in 
protocols. If interviews showed obvious problems with specific questions 
difficult situations in routine practice. They argue that such 
prescribing behavior, while being considered irrational from a 
medico-scientific perspective, is rational in the broadest sense 
of problem-solving acknowledging the humanity of the thera-
peutic relationship. This challenges the usual definition of ra-
tional prescribing. Further, qualitative studies on the inade-
quate prescription of antibiotics in case of sore throats or colds 
[10, 11] found even more evidence suggesting that GPs do not 
apply nonspecific interventions mainly to trigger placebo ef-
fects. In these studies the word placebo or the idea of trigger-
ing placebo effects did not come up at all while surveys on the 
use of placebo often consider this as a typical example of a 
placebo prescription [1].
Compared to other specialties, the use of nonspecific inter-
ventions or impure placebos seems to be particularly wide-
spread among GPs [1, 6, 12–14]. This is plausible when consid-
ering that GPs see many patients with complaints not easy to 
diagnose precisely [15] and who have minor ailments [16]. We 
would expect that for specialists of internal medicine who 
mainly see preselected cases with more advanced disease and 
clear diagnoses receiving multiple treatments, the use of im-
pure placebo is less often an option. We speculate that ortho-
pedic specialists in private practice are a particularly interest-
ing group with respect to our subject but we are not aware of 
any studies investigating placebo use among this group. Ortho-
pedists are trained in hospitals with strong emphasis on surgi-
cal techniques while in private practice they see a lot of pa-
tients with relatively nonspecific complaints [17]. One could 
therefore assume that orthopedists often feel strong uncer-
tainty towards their patients and do not have straightforward 
evidence-based treatment options. Thus, we would expect that 
they use nonspecific treatments less often than GPs but more 
often than specialists in internal medicine. 
We hypothesize that there should also be a relation be-
tween the use of complementary and alternative treatments 
(such as herbal medicine, acupuncture, homeopathy, chiro-
practic or osteopathy) and nonspecific treatments. Comple-
mentary medicine offers, or seems to offer, ‘specific’ diagnostic 
and therapeutic solutions for many patients for whom conven-
tional medicine does not provide satisfactory answers. Believ-
ing in the efficacy and using complementary treatments could 
therefore be a way of reducing uncertainty and keeping pro-
fessional ideals (while maybe implying some conflict with pro-
fessional orthodoxy). If this proved true, one should expect 
that providers of complementary treatments have less need 
for using treatments they personally consider to be nonspecif-
ic. At the same time we think that convinced providers of com-
plementary treatments also believe in a strong mind-body con-
nection and strong placebo effects. One could therefore as-
sume that they are more open towards the use of placebo 
interventions. Finally, a consistent finding in surveys from 
 Germany and Switzerland is that many physicians use comple-
mentary treatment as impure placebos / nonspecific interven-
tion [6, 13, 18]. It would be interesting to know whether these 
Theoretical Considerations for Questionnaire Development
While most published placebo surveys include questions on 
reasons and motives for the use of placebos and nonspecific 
treatments authors rarely discuss on a conceptual level why 
physicians use such interventions. It seems that many survey 
authors implicitly think that eliciting placebo effects is a major 
motive and that the use of placebo interventions would be le-
gitimate if the patient would not be deceived. Instead, our cen-
tral assumption is that impure placebos / nonspecific treat-
ments are applied to deal with uncertain and difficult situations 
in clinical practice. This assumption is based on a number of 
qualitative investigations exploring reasons why physicians 
sometimes use interventions they do not consider active or ad-
equate. In a study by Comaroff [7] published in 1976 the atti-
tudes of 51 GPs in Wales toward placebos and nonspecific 
treatments were surveyed indirectly, in the context of a more 
general discussion about prescribing behavior. Practitioners 
were first asked to estimate the proportion of their consulta-
tions culminating in a treatment prescription. All participants 
set the proportion at 70% or higher. In their elaborate answers, 
most practitioners spontaneously stated that they did not con-
sider all prescriptions as truly necessary and felt necessitated to 
provide justifications. Implicitly the answers clearly indicated 
that the physicians had internalized a professional ideal requir-
ing that any treatment should be specific in effect and adminis-
tered or prescribed only when necessary. However, this ideal 
conflicted with the realities of GPs in routine practice. Seeing 
only unselected patients, GPs faced considerable uncertainty 
but still needed to make decisions. On the one hand, making a 
firm diagnosis in general practice was often impossible or un-
necessary, implying that the basis for choosing a specific treat-
ment was weak. On the other hand, physicians usually believed 
that patients expected a clear diagnosis and a treatment. There-
fore, the GPs often used nonspecific treatments.
Research on difficult prescribing situations also suggests 
that ideals and self-perception of physicians might be more 
important reasons for prescribing placebos or nonspecific 
treatment than the triggering of placebo effects. Henriksen 
and Hansen [8] interviewed 20 GPs to investigate their self-
perception in relation to prescribing medicine. The study fo-
cused on threats to the self-image in a general manner, but 
clearly nonspecific interventions played a major role. Also this 
study found that an orientation towards human or scientific 
ideals was implicitly fundamental to the physicians. However, 
multiple factors made it difficult to live up to the ideals. Due to 
patient demand, lack of time or the need to do any kind of 
treatment physicians gave prescriptions against their convic-
tions in given situations. To be able to face themselves in the 
mirror physicians developed strategies to protect themselves. 
They tried to set the ideals realistically, take a stand, and be-
lieve in themselves. A qualitative study by Weiss and Scott [9] 
suggests that nonspecific interventions (called ‘irrational pre-
scribing’ in the paper) and prescribing in general are seen as a 
problem-solving tool which can be used to manage a variety of 
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terviews themselves, the term placebo was always associated 
primarily with pure placebos. The term nonspecific treatment 
was considered more familiar, but still difficult. There were 
considerable discussions on how to best paraphrase and ex-
plain nonspecific treatments but no solution seemed optimal. 
The example of applying antibiotics in case of a patient likely 
to suffer from a viral infection was obvious to all interviewed 
GPs and internists, but not to the orthopedists (therefore an-
other example was chosen for this group). However, these ter-
minological issues did not seem to create major problems in 
understanding the questions in principle and to answer them 
in a relatively straightforward way. Still, while our wording in 
this block seems to be understood in general it is clear that 
there is some ambiguity remaining and room for interpreta-
tion to the physicians.
Block C (fig. 1 C) includes 21 questions concerning the at-
titudes toward and the use of complementary therapies. First, 
physicians are asked to mark on a 5-point scale whether they 
consider 7 listed complementary therapies widespread in Ger-
many to be more effective than placebo. In the following ques-
 
 10
Block D: Statements on practical work and basic professional 
attitudes 
Please mark on the scales to which extent the following statements apply to you 
 Fully agree 
Tend to 
agree 
Tend to 
dis-
agree 
Fully 
dis-
agree 
29. With complementary therapies I have a systematic tool 
for patients in whom conventional medicine offers few 
options 
 
 
O 
 
O 
 
O 
 
O 
30. I only use therapies if I am personally convinced of these 
therapies  
 
 
O 
 
O 
 
O 
 
O 
31. An intense and continuous relationship with the patient is 
fundamental to my daily practical work  
 
 
O 
 
O 
 
O 
 
O 
32. If I could I would spend much more time to listen and talk 
with my patients  
 
 
O 
 
O 
 
O 
 
O 
33. If I had more time to listen and talk with my patients I 
would well be able to use this time for the patient-doctor 
relationship 
 
 
O 
 
O 
 
O 
 
O 
34. Most patients expect to receive a treatment/a 
prescription 
 
 
O 
 
O 
 
O 
 
O 
35. A treatment should be prescribed/applied only if 
treatment is really needed 
 
 
O 
 
O 
 
O 
 
O 
36. Whenever possible only evidence-based treatment 
should be used 
 
 
O 
 
O 
 
O 
 
O 
37. The use of placebos should be avoided whenever 
possible  
 
 
O 
 
O 
 
O 
 
O 
38. As a physician one should intensively harness positive 
psychological effects (e.g. “drug physician“)  
 
 
O 
 
O 
 
O 
 
O 
39. Medical school and postgraduate training prepared me 
well for my daily work in practice  
 
 
O 
 
O 
 
O 
 
O 
40. For many patients it is not possible to establish an exact 
diagnosis in my daily practice 
 
 
O 
 
O 
 
O 
 
O 
41. In my daily practice I am confronted with many patients 
in which the classical knowledge from textbooks is 
insufficient 
 
O 
 
O 
 
O 
 
O 
  
Fig. 1 D. Statements on practical work and basic professional attitudes.
these were modified before the following interviews. The interview phase 
led to some slight changes of the wording of the questions on the use of 
pure placebos and nonspecific interventions and to some more profound 
changes of the questions on professional attitudes in the final version of 
the questionnaire.
Results
The final questionnaire consists of 50 questions on 4 pages 
and is divided in 5 blocks. Block A (fig. 1 A) consists of 4 ques-
tions on the use of ‘typical’ placebos (defined as ‘preparations 
without active ingredients such as placebo pills or saline injec-
tions’): use, number of patients who received placebo in the 
last 12 months, number of patients who received a placebo on 
more than one occasion, and availability of readymade placebo 
preparations (e.g., sugar pills) in practice. These questions had 
been included in our previous survey [6] but were modified 
slightly based on experiences from the survey and the cogni-
tive interviews. For example, in the previous survey 21% of 
respondents reported that they have placebo preparations in 
their practice. However, some remarks on questionnaires and 
the interviews revealed that this includes saline preparations 
that, obviously, are available in any practice. To solve this prob-
lem, we now ask physicians to report the type of placebos they 
have in their practice. However, in general this block seems to 
be understood without any problems as physicians intuitively 
equate placebo or typical placebo with pure placebo.
Instead, terminological problems were obvious in block B 
(fig. 1 B) concerning nonspecific treatments defined in the 
questionnaire as drugs or treatments that do not have any in-
trinsic effect on the illness of the patient or on the symptoms. 
This block comprises 3 questions: use, frequency of use in the 
last 12 months, and type of interventions used as nonspecific 
treatment (11 answer options; collection based on available 
surveys [1, 6]). The cognitive interviews clearly confirmed that 
the concept of impure placebos is unfamiliar and confusing to 
physicians. Although several physicians used impure placebos 
as examples for placebo interventions in the course of the in-
 
 8
Block A: Use of typical placebos 
1. Have you ever used placebos (preparations without active ingredients such as placebo 
pills or saline injections) for treatment outside of clinical trials in your practice? 
 O yes     O no (please go to questions 5) 
 
2. Please give an estimate in how many patients you used a placebo in the last 12 months?  
 in about _____ patients in the last 12 months 
 
3. Were there any patients who received a placebo more than once in the last 12 months? 
 O no    O yes, about __________ patients 
 
4. Do you have ready-made placebo preparations (e.g. sugar tablets) available in your 
practice? 
 O no     O yes, the following type: _________________ 
 
2. Please give an estimate in how many patients you used such a non-specific treatment in 
the last 12 months? 
 in about _____ patients in the last 12 months 
 
3. What types of drugs/treatments have you already used as non-specific treatment? (check 
all that apply)  
Please note that here we only ask for situations in which you personally thought that the treatment 
would have no intrinsic/specific effect on the symptoms, not the use of such treatments in general!
 O Micronutrients 
 O Vitamines 
 O Sedatives (e.g. zopiclon, opipramol, chloralhydrat) 
 O Antibiotics 
  O Analgesics or NSAIDs 
  O Drugs in subtherapeutic dosage 
 O Homeopathic remedies  
 O Herbal remedies 
 O Acupuncture 
 O Manual therapies 
 O Other:  ___________________________________________________  Fig. 1 B. Questionnaire block B: use of nonspecific treatments. 
 
Fig. 1 A. Use of typical placebos.
 
 
Block B: Use of non-specific treatments 
1. Have you ever used in your practice drugs or treatments even though you thought that 
these did not have any intrinsic effect against the illness of the patient or on its symptoms 
(e.g. antibiotics in a patient likely to suffer from a viral infection or a herbal remedy 
although you personally thought it is without effect on the specific symptoms)? 
 O yes     O no (please go to question 8) 
 
2. Please give an estimate in how many patients you used such a non-specific treatment in 
the last 12 months? 
 in about _____ patients in the last 12 months 
 
3. What types of drugs/treatments have you already used as non-specific treatment? (check 
all that apply)  
Please note that here we only ask for situations in which you personally thought that the treatment 
would have no intrinsic/specific effect on the symptoms, not the use of such treatments in general!
 O Micronutrients 
 O Vitamines 
 O Sedatives (e.g. zopiclon, opipramol, chloralhydrat) 
 O Antibiotics 
  O Analgesics or NSAIDs 
  O Drugs in subtherapeutic dosage 
 O Homeopathic remedies  
 O Herbal remedies 
 O Acupuncture 
 O Manual therapies 
 O Other:  ___________________________________________________  
Fig. 1 B. Use of nonspecific treatments.
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Block C: Attitudes to and use of complementary therapies
Please mark on how you rate the following therapies regarding the clinical effects over placebo 
 Is a 
placebo 
treatment 
Rather a 
placebo 
treatment 
Partly/ 
don’t 
know 
Rather 
more than 
a placebo 
Is more 
than a 
placebo 
  8. Acupuncture O O O O O 
  9. Homeopathy O O O O O 
10. Osteopathy O O O O O 
11. Chirotherapy O O O O O 
12. Herbal remedies O O O O O 
13. Other naturopathic treatments O O O O O 
14. Vitamins/Micronutrients O O O O O 
Please mark how often you use the following therapies in your practice 
 Never < 1x per 
month 
1-4x per 
month 
> 4x per 
month 
Every day 
15. Acupuncture O O O O O 
16. Homeopathic remedies O O O O O 
17. Osteopathy O O O O O 
18. Chirotherapy O O O O O 
19. Herbal remedies O O O O O 
20. Other naturopathic treatments O O O O O 
21. Vitamins/Micronutrients O O O O O 
22. Other complementary therapies:  
_____________________________ 
O O O O O 
Are you certified for one of the following therapies or are you in the process of obtaining such 
a certification? 
 I am certified for I am in the process of 
obtaining th 
certification for 
Neither nor 
23. Acupuncture O O O 
24. Homeopathy O O O 
25. Manual medicine/Chirotherapy O O O 
26. Naturopathy O O O 
27. Other:___________________ O O  
28. Andere:___________________ O O  
  
Fig. 1 C. Attitudes to and use of complementary therapies.
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tions physicians are asked to indicate how often they use these 
7 therapies (with an additional possibility to report other com-
plementary therapies not mentioned). Finally physicians are 
asked whether they hold certificates for the 4 complementary 
therapies officially accredited by the German Medical Associ-
ation; the possibility to indicate 2 other treatments is also giv-
en. These questions were understood and answered without 
any relevant problem.
Block D (fig. 1 D) comprises 13 statements on practical 
work and basic professional attitudes. Physicians are asked to 
indicate the level of agreement on a 4-point scale. The state-
ments are mainly based on the theoretical considerations sum-
marized above and in other publications [20]. Pilot testing and 
cognitive interviews revealed considerable problems with the 
understanding of several important statements included in the 
initial version of the questionnaire. We had tried to confront 
physicians immediately and directly with the key statement ‘a 
treatment should only be prescribed or applied if it is neces-
sary and effective (beyond a placebo effect)’ based on the 
findings by Comaroff summarized above [7]. There was only 
one missing answer in the pretest. Answers varied strongly 
(22% fully agreed, 54% tended to agree, 15% tended to disa-
gree, and 9% fully disagreed) indicating that either Comaroff’s 
terviews themselves, the term placebo was always associated 
primarily with pure placebos. The term nonspecific treatment 
was considered more familiar, but still difficult. There were 
considerable discussions on how to best paraphrase and ex-
plain nonspecific treatments but no solution seemed optimal. 
The example of applying antibiotics in case of a patient likely 
to suffer from a viral infection was obvious to all interviewed 
GPs and internists, but not to the orthopedists (therefore an-
other example was chosen for this group). However, these ter-
minological issues did not seem to create major problems in 
understanding the questions in principle and to answer them 
in a relatively straightforward way. Still, while our wording in 
this block seems to be understood in general it is clear that 
there is some ambiguity remaining and room for interpreta-
tion to the physicians.
Block C (fig. 1 C) includes 21 questions concerning the at-
titudes toward and the use of complementary therapies. First, 
physicians are asked to mark on a 5-point scale whether they 
consider 7 listed complementary therapies widespread in Ger-
many to be more effective than placebo. In the following ques-
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Block D: Statements on practical work and basic professional 
attitudes 
Please mark on the scales to which extent the following statements apply to you 
 Fully agree 
Tend to 
agree 
Tend to 
dis-
agree 
Fully 
dis-
agree 
29. With complementary therapies I have a systematic tool 
for patients in whom conventional medicine offers few 
options 
 
 
O 
 
O 
 
O 
 
O 
30. I only use therapies if I am personally convinced of these 
therapies  
 
 
O 
 
O 
 
O 
 
O 
31. An intense and continuous relationship with the patient is 
fundamental to my daily practical work  
 
 
O 
 
O 
 
O 
 
O 
32. If I could I would spend much more time to listen and talk 
with my patients  
 
 
O 
 
O 
 
O 
 
O 
33. If I had more time to listen and talk with my patients I 
would well be able to use this time for the patient-doctor 
relationship 
 
 
O 
 
O 
 
O 
 
O 
34. Most patients expect to receive a treatment/a 
prescription 
 
 
O 
 
O 
 
O 
 
O 
35. A treatment should be prescribed/applied only if 
treatment is really needed 
 
 
O 
 
O 
 
O 
 
O 
36. Whenever possible only evidence-based treatment 
should be used 
 
 
O 
 
O 
 
O 
 
O 
37. The use of placebos should be avoided whenever 
possible  
 
 
O 
 
O 
 
O 
 
O 
38. As a physician one should intensively harness positive 
psychological effects (e.g. “drug physician“)  
 
 
O 
 
O 
 
O 
 
O 
39. Medical school and postgraduate training prepared me 
well for my daily work in practice  
 
 
O 
 
O 
 
O 
 
O 
40. For many patients it is not possible to establish an exact 
diagnosis in my daily practice 
 
 
O 
 
O 
 
O 
 
O 
41. In my daily practice I am confronted with many patients 
in which the classical knowledge from textbooks is 
insufficient 
 
O 
 
O 
 
O 
 
O 
  
Fig. 1 D. Statements on practical work and basic professional attitudes.
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Block E: Questions on yourself and your practice 
 
42. Year of birth 
  19_______ 
 
43. Gender 
  O female    O male 
 
44. Working in private practice since 
  _______ years 
 
45. How many hours per week do you work as a physician 
  O full-time ca. ______ hours per week        O part-time ca. ______ hours per week 
 
46. Type of practice 
 O not licensed for social health insurance O licensed for social health insurance 
 
47. Do you have a specific focus within your discipline shaping your daily practice (e.g. 
cardiology, palliative medicine)? 
 O no    O yes_____________________________________________
 
48. My practice is located  
 O in a city with more than 100.000 residents 
 O in a town with 10.000 to 100.000 residents 
  O in village with less than 10.000 residents 
 
49. How would you rate the economic status of your patients on average? 
 O tendency rich O very mixed  O tendency poor 
 
50. Do you want to be informed about the results of this survey? 
 O no    O yes 
 
 
Do you have any comments? 
 
 
 
Thank you for your collaboration! 
  
Fig. 1 E. Questions on yourself and your practice.
 
 
Block B: Use of non-specific treatments 
1. Have you ever used in your practice drugs or treatments even though you thought that 
these did not have any intrinsic effect against the illness of the patient or on its symptoms 
(e.g. antibiotics in a patient likely to suffer from a viral infection or a herbal remedy 
although you personally thought it is without effect on the specific symptoms)? 
 O yes     O no (please go to question 8) 
 
2. Please give an estimate in how many patients you used such a non-specific treatment in 
the last 12 months? 
 in about _____ patients in the last 12 months 
 
3. What types of drugs/treatments have you already used as non-specific treatment? (check 
all that apply)  
Please note that here we only ask for situations in which you personally thought that the treatment 
would have no intrinsic/specific effect on the symptoms, not the use of such treatments in general!
 O Micronutrients 
 O Vitamines 
 O Sedatives (e.g. zopiclon, opipramol, chloralhydrat) 
 O Antibiotics 
  O Analgesics or NSAIDs 
  O Drugs in subtherapeutic dosage 
 O Homeopathic remedies  
 O Herbal remedies 
 O Acupuncture 
 O Manual therapies 
 O Other:  ___________________________________________________  
Fig. 1 B. Use of nonspecific treatments.
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Block C: Attitudes to and use of complementary therapies
Please mark on how you rate the following therapies regarding the clinical effects over placebo 
 Is a 
placebo 
treatment 
Rather a 
placebo 
treatment 
Partly/ 
don’t 
know 
Rather 
more than 
a placebo 
Is more 
than a 
placebo 
  8. Acupuncture O O O O O 
  9. Homeopathy O O O O O 
10. Osteopathy O O O O O 
11. Chirotherapy O O O O O 
12. Herbal remedies O O O O O 
13. Other naturopathic treatments O O O O O 
14. Vitamins/Micronutrients O O O O O 
Please mark how often you use the following therapies in your practice 
 Never < 1x per 
month 
1-4x per 
month 
> 4x per 
month 
Every day 
15. Acupuncture O O O O O 
16. Homeopathic remedies O O O O O 
17. Osteopathy O O O O O 
18. Chirotherapy O O O O O 
19. Herbal remedies O O O O O 
20. Other naturopathic treatments O O O O O 
21. Vitamins/Micronutrients O O O O O 
22. Other complementary therapies:  
_____________________________ 
O O O O O 
Are you certified for one of the following therapies or are you in the process of obtaining such 
a certification? 
 I am certified for I am in the process of 
obtaining th 
certification for 
Neither nor 
23. Acupuncture O O O 
24. Homeopathy O O O 
25. Manual medicine/Chirotherapy O O O 
26. Naturopathy O O O 
27. Other:___________________ O O  
28. Andere:___________________ O O  
  
Fig. 1 C. Attitudes to and use of complementary therapies.
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the emphasis on basic professional attitudes and the link be-
tween placebo and complementary and alternative medicine. 
On the other hand, we do not ask how physicians practically 
apply pure placebos and nonspecific interventions, why such 
interventions are used, and what physicians tell patients in 
these instances.
Our survey is currently (January 2013) in the data collec-
tion phase. Questionnaires have been sent to each 700 GPs, 
internists, and orthopedists randomly selected from a commer-
cially available address database which covers more than 80% 
of physicians working in private practice in Germany. Physi-
cians not responding to the first contact receive up to 2 re-
minders. Postal surveys among physicians often suffer from 
very low response rates [21]. Unfortunately, we were unable to 
obtain funding to include an nonbinding incentive (a book 
voucher of EUR 10) in the first letter, as there is good evi-
dence that this single measure is highly effective in increasing 
response rate [21, 22]. In our cognitive interviews we also 
asked the physicians whether they would fill out the question-
naire if they found it in their mail and how to increase chances 
of response. All interviewed physicians agreed that the letter 
should clearly state that the survey is the basis for a medical 
thesis (it must kept in mind, however, that the interviewer was 
a doctorate candidate) as most physicians remember how 
much they depended on others when they did their own thesis. 
We consider a response rate of 40% as a realistic target but 
hope to receive an even higher result.
While quantitative surveys on this topic are relevant it is 
obvious that more qualitative studies are needed to really un-
derstand when, how, and why placebos and nonspecific treat-
ments are used in routine practice. Interviewing physicians 
individually and focusing group discussions are logical first 
steps, but what physicians think and say might not fully indi-
cate what they actually do. Therefore, direct observation of 
practice might be necessary at some point. 
We are confident that our survey will provide solid findings 
about the frequency of the use of pure and impure placebo 
interventions in Germany and its association with attitudes to-
ward the use of complementary therapies. We hope that we 
also will get some insights regarding the relation between ba-
sic professional attitudes and placebo use.
Acknowledgement
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conclusion is wrong or that the question was not understood. 
The cognitive interviews strongly suggest that probably many 
physicians answered in a manner that already reflected the 
tension between the ideal (to which they agreed in principle) 
and what is realistic in practice. Regarding a related question 
one internist said: ‘Everyone who reflects his work somewhat 
critically, who thinks a bit about himself, he will not be able to 
give an absolute answer here. He will rate somewhere in the 
middle…’. Furthermore, it was unclear what was considered 
effective compared to placebo and whether it was related to 
personal belief or scientific proof. Thus we gave up the idea of 
investigating whether the doctors agree with the implicit pro-
fessional ideals. In the final version the statement is separated 
into 2 statements and instead of speaking of effects over pla-
cebo we use the wording ‘evidence-based treatments’. In gen-
eral, physicians had little problems to mark their answers in 
this section, but the interviews made clear that the complexity 
of the issues addressed could not be fully grasped in the state-
ments, and that there is considerable room for subjective inter-
pretation. It seems unlikely that this could be improved funda-
mentally in the final version although we did our best. 
Therefore, the findings related to this section will have to be 
interpreted with caution.
Finally Block E (fig 1 E) documents basic information on 
the physicians (birth year, gender, working experience, type of 
practice, specialties, location, and average economic status of 
patients) and whether physicians want to be informed about 
the results of the survey.
Discussion
Based on a review of the available literature [1], own expe-
rience in surveys, and against the background of theoretical 
considerations we have systematically developed a 4-page 
questionnaire to collect reliable data on the use of placebos as 
well as nonspecific and complementary treatments and their 
relation to basic professional attitudes among physicians in 
Germany. We are aware that particularly the use of nonspecific 
treatments and basic professional attitudes are difficult to in-
vestigate with a standardized questionnaire. The results ob-
tained (as those of previous surveys) will have to be consid-
ered with caution due to the unavoidable terminological 
ambiguities. We did not run another pretest after revising the 
questionnaire based on the interviews as resources were lim-
ited, most changes were minor, and a quantitative pretest 
seemed inappropriate to check whether the major changes in 
the statements on basic professional attitudes led to noticeable 
improvements. We want to emphasize that our questionnaire 
might not be easy to apply in other countries where the use of 
complementary treatments by physicians is less frequent.
Our survey differs considerably from most available quan-
titative surveys. On the one hand, a main focus of our survey is 
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thesis (it must kept in mind, however, that the interviewer was 
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much they depended on others when they did their own thesis. 
We consider a response rate of 40% as a realistic target but 
hope to receive an even higher result.
While quantitative surveys on this topic are relevant it is 
obvious that more qualitative studies are needed to really un-
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ments are used in routine practice. Interviewing physicians 
individually and focusing group discussions are logical first 
steps, but what physicians think and say might not fully indi-
cate what they actually do. Therefore, direct observation of 
practice might be necessary at some point. 
We are confident that our survey will provide solid findings 
about the frequency of the use of pure and impure placebo 
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